The Latest News
Orthosensor Completes $19 Million Funding Round; Second investment for Tullis Growth Fund
OrthoSensor, a Florida-based maker of knee implant placement technology, has completed a $19 million funding round. The Series C round was financed by a combination of existing investors and Tullis Health Investors who made its first investment into the company through the Tullis Growth Fund. This is the second investment for the Tullis Growth Fund. OrthoSensor had earlier closed a $48 million Series B round in October 2013, just after its Verasense device gained a CE Mark approval in the European Union. The Verasense device is designed to help surgeons measure proper placement and motion during total knee replacement procedures. The FDA granted 510(k) clearance to the VeraSense device in June 2013.